4//SEC Filing
Furlong Tammy 4
Accession 0001415889-25-004609
CIK 0001783032other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:20 PM ET
Size
16.6 KB
Accession
0001415889-25-004609
Insider Transaction Report
Form 4
Furlong Tammy
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-02-15−300→ 2,400 total→ Common Stock (300 underlying) - Exercise/Conversion
Common Stock
2025-02-15+9,375→ 10,785 total - Tax Payment
Common Stock
2025-02-15$0.67/sh−2,780$1,867→ 8,005 total - Exercise/Conversion
Common Stock
2025-02-15+300→ 8,305 total - Tax Payment
Common Stock
2025-02-15$0.67/sh−89$60→ 8,216 total - Award
Stock Option (Right to Buy)
2025-02-15+275,000→ 275,000 totalExercise: $0.67Exp: 2035-02-14→ Common Stock (275,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-15−9,375→ 28,125 total→ Common Stock (9,375 underlying)
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The stock option vests as to 25% of the total shares on February 15, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F3]25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F4]The RSUs do not expire; they either vest or are canceled prior to the vesting date.
- [F5]25% of the RSUs vested on February 15, 2024, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
Elevation Oncology, Inc.
CIK 0001783032
Entity typeother
Related Parties
1- filerCIK 0001984204
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:20 PM ET
- Size
- 16.6 KB